Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.04, revenue of $1.74B beats by $40M
Seeking Alpha ·
Edwards Lifesciences press release ( EW ): Q2 Non-GAAP EPS of $0.78 beats by $0.04 . Revenue of $1.74B (+13.7% Y/Y) beats by $40M . Based on the company’s second quarter performance, Edwards is increasing its full-year 2026 sales growth rate guidance to 10% to 11% from
DYAX Investor Sentiment
Bullish (Long) 60% · Bearish (Short) 40%
467 participants
Related News
- Safety Insurance agrees to $1.54B Mapfre buyout deal; shares soar 35% in after-hours
- Ovintiv GAAP EPS of $1.62 misses by $0.49
- U.S. Century Bank GAAP EPS of $0.49 in-line, revenue of $27.95M beats by $1.21M
- CNB Financial Non-GAAP EPS of $0.63, revenue of $87.6M
- Update: US Equity Indexes Slump, Crude Oil Soars as Trump Warns of Big Iran Attack
- Pentagon awards Oracle nearly $7 billion deal in latest software consolidation push
